Frailty and the Risk of Age-Related Macular Degeneration: A Prospective Cohort and Mendelian Randomization Study
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 10.02.2025 · 80 (3)
DOI: 10.1093/gerona/glae300 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 23.12.2024. Verfasst von Xinyu Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Macular Degeneration, Frailty, Frail Elderly. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Both frailty and age-related macular degeneration (AMD) are related to aging and may share some common mechanisms. We aimed to examine the observational and causal association between frailty and the risk of AMD.
Methods
We included 320 810 participants free of AMD at baseline from the UK Biobank. Frailty phenotypes were defined according to 5 components: weight loss, exhaustion, slow gait speed, low grip strength, and low physical activity. Cox proportional hazard models were used to evaluate the association between frailty phenotype and the risk of AMD. A causal relationship between frailty phenotype and AMD was examined using 2-sample Mendelian randomization (MR) analysis.
Results
During a median follow-up of 12.81 years, 7 222 AMD cases were documented. After adjusting for confounding factors, compared with nonfrail participants, both pre-frail and frail participants were significantly associated with an increased risk of AMD (hazard ratio [HR] 1.17, [95% confidence interval {CI}: 1.11, 1.23] for pre-frailty and HR 1.55 [95% CI: 1.40, 1.73] for frailty). With each 1-point increase in frailty phenotype score, the risk of AMD increased by 14%. Results from the 2-sample MR analysis supported the potential causal effect of frailty phenotype on AMD.
Conclusions
Our findings suggested that frailty assessment may help identify at-risk populations and serve as a potential strategy for early prevention and management of AMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis…
- Department of Ophthalmology, Ningde Municipal Hospital, Ningde Normal University, Ningde, China.
- Department of Ophthalmology, Wuxi No.2 People's Hospital, Jiangnan University Medical Center, Wuxi, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, X., Huang, Y., Liang, L., Zhang, X., Zhang, Z., Jiang, Y., Wu, X., Li, C., Zheng, Z., Bao, Z., Zou, W., & Zhao, S. (2025). Frailty and the Risk of Age-Related Macular Degeneration: A Prospective Cohort and Mendelian Randomization Study. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 80(3). https://doi.org/10.1093/gerona/glae300
Vancouver
Zhu X, Huang Y, Liang L, Zhang X, Zhang Z, Jiang Y, et al. Frailty and the Risk of Age-Related Macular Degeneration: A Prospective Cohort and Mendelian Randomization Study. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025;80(3). doi:10.1093/gerona/glae300
BibTeX
@article{Zhu2025,
author = {Zhu, Xinyu and Huang, Yikeng and Liang, Li and Zhang, Xinyu and Zhang, Zixuan and Jiang, Yujin and Wu, Xiaoqian and Li, Chenxin and Zheng, Zhi and Bao, Zhangli and Zou, Wenjun and Zhao, Shuzhi},
title = {Frailty and the Risk of Age-Related Macular Degeneration: A Prospective Cohort and Mendelian Randomization Study},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2025},
volume = {80},
number = {3},
doi = {10.1093/gerona/glae300}
}
EUVIMED